MAAT INDEX

CLAIM #41401 · MetLife Inc (MET) · 2026Q1 earnings call · May 7, 2026 · due Dec 31, 2026

And I would just add, Pablo, just in terms of outlook, we probably -- obviously, this is a very strong quarter. I wouldn't consider this to be a run rate where we had a $90 million to $100 million quarterly run rate as part of the outlook. And we're probably trending towards the middle to upper end of that range is where we -- going forward.

John McCallion · CFO

PENDING
graded after results covering Dec 31, 2026 are reported

How to check this claim

Look at: EMEA segment quarterly adjusted earnings (or the specific business line referenced with the $90-100M run rate)

It came true if: Quarterly run rate between $95 million and $100 million (middle to upper end of the $90-100M range)

Where: MetLife quarterly earnings release / 10-Q segment results (EMEA)

In context

tive of the highly efficient structure that we have in EMEA, especially in Europe. With regard to the situation in the Middle East, just to give you a sense of EMEA's earnings, about 2/3 come from Europe, 1/3 from the rest of the region. And about 50% of that 1/3 comes from Turkey and Egypt. So clearly, we've been keeping a close eye on what's happening in the region. Our first order priority is the safety and well-being of our associates there. So far, we have not seen any impact. And I think EMEA's performance in the quarter is -- provides evidence of that. And we think that, provided the situation stabilizes from here, we're not going to see any impact. And if we do, they're not going to be material to EMEA overall and certainly not to MetLife's overall results as well. John McCallion: And I would just add, Pablo, just in terms of outlook, we probably -- obviously, this is a very strong quarter. I wouldn't consider this to be a run rate where we had a $90 million to $100 million quarterly run rate as part of the outlook. And we're probably trending towards the middle to upper end of that range is where we -- going forward. Pablo Singzon: That's clear. And then my second question, disability, maybe for Ramy again. Do you think the trends you've seen so far, right? You called out severity, paid families, would those require repricing beyond normal course? And I guess, how do you frame how you might be positioning the book today versus the past several years when results for the industry were just very strong? Lyndon Oliver: Yes. Well, just in terms of our overall approach for pricing here, we have the ability to reprice about 50% of the book every year in terms of our disability book. And that's driven by a combination of would be client-specific experience as well as our outlook. I would say from an LTD perspective, what we've seen from a 1 quarter of severity this quarter, and I talked about this being flat

Verify independently

SEC filings for MET · Claim quote is verbatim from the 2026Q1 earnings call.